COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,963 Articles (22,604 medRxiv, 8,359 bioRxiv)

Most recent first Previous |  Page 2379: Articles 23781-23790  | Next

New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release
Tomaszewski, T., DeVries, R. S., Dong, M., Bhatia, G., Norsworthy, M. D., Zheng, X., Caetano-Anolles, G.
10.1101/2020.07.31.231472 — Posted: 2020-07-31
SARS-CoV-2 protein subunit vaccination elicits potent neutralizing antibody responses
Mandolesi, M., Sheward, D. J., Hanke, L., Ma, J., Pushparaj, P., Perez Vidakovics, L., Kim, C., Lore, K., Castro Dopico, X., Coquet, J. M., McInerney, G., Karlsson Hedestam, G. B., Murrell, B.
10.1101/2020.07.31.228486 — Posted: 2020-07-31
Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase
Mickolajczyk, K. J., Shelton, P. M. M., Grasso, M., Cao, X., Warrington, S. R., Aher, A., Liu, S., Kapoor, T. M.
10.1101/2020.07.31.231274 — Posted: 2020-07-31
SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, ER stress and DNA synthesis
Wang, Y., Huang, J., Sun, Y., He, J., Li, W., Liu, Z., Taylor, E. W., Rayman, M. P., Wan, X., Zhang, J.
10.1101/2020.07.31.230243 — Posted: 2020-07-31
Study on β-Chitosan against the binding of SARS-CoV-2S-RBD/ACE2
Alitongbieke, G., Li, X.-M., Wu, Q.-C., Lin, Z.-C., Huang, J.-F., Xue, Y., Liu, J.-N., Lin, J.-M., Pan, T., Chen, Y.-X., Su, Y., Zhang, G.-G., Leng, B., Liu, S.-W., Pan, Y.-T.
10.1101/2020.07.31.229781 — Posted: 2020-07-31
Computer Simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces
Malaspina, D. C., Faraudo, J.
10.1101/2020.07.31.230888 — Posted: 2020-07-31
Biochemical and mathematical lessons from the evolution of the SARS-CoV-2 virus: paths for novel antiviral warfare
Cluzel, N., Lambert, A., Maday, Y., Turinici, G., Danchin, A.
10.1101/2020.07.31.230607 — Posted: 2020-07-31 Discussion: Offsite
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine
Sun, W., McCroskery, S., Liu, W.-C., Leist, S. R., Liu, Y., Albrecht, R. A., Slamanig, S., Oliva, J., Amanat, F., Schaefer, A., Dinnon, K. H., Innis, B. L., Garcia-Sastre, A., Krammer, F., Baric, R. S., Palese, P.
10.1101/2020.07.30.229120 — Posted: 2020-07-31 Discussion: Onsite | Offsite
Phylogenomic analysis of SARS-CoV-2 genomes from western India reveals unique linked mutations
Paul, D., Jani, K., Kumar, J., Chauhan, R., Seshadri, V., Lal, G., Karyakarte, R., Joshi, S., Tambe, M., Sen, S., Karade, S., Anand, K. B., Shergill, S. P. S., Gupta, R. M., Bhat, M. K., Sahu, A., Shouche, Y. S.
10.1101/2020.07.30.228460 — Posted: 2020-07-31
Global variation in the SARS-CoV-2 proteome reveals the mutational hotspots in the drug and vaccine candidates
Patro, L. P. P., Sathyaseelan, C., Uttamrao, P. P., Rathinavelan, T.
10.1101/2020.07.31.230987 — Posted: 2020-07-31 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).